Yu-Kyong Kim

8PUBLICATIONS
22CO-AUTHORS
Pharmaceutical delivery technologiesEpigenetics (incl. genome methylation and epigenomics)Other European languagesMedical molecular engineering of nucleic acids and proteinsPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 28, 2023
Pharmacokinetic and Pharmacodynamic Characteristics of Pelubiprofen Tromethamine vs. Pelubiprofen in Healthy Subjects.

Yu-Jeong Son, Min-Kyu Park, Hyeon-Jeong Park

|Apr 20, 2023
Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects.

Hyun Chul Kim, Eunsol Yang, Mu Seong Ban

|Jan 12, 2023
Common ABCB1 SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject.

Jun Gi Hwang, Sae Im Jeong, Yu Kyong Kim

|Aug 16, 2021
The necessary conduct: Exploratory multiregional clinical trials in East Asia.

Inseung Jeon, Yu Kyong Kim, Ildae Song

|Jul 30, 2021
Influence of Renal Function on the Single-Dose Pharmacokinetics of Besifovir, a Novel Antiviral Agent for theTreatment of Hepatitis B Virus Infection.

Jun Gi Hwang, Yu Kyong Kim, Young-Sim Choi

|May 06, 2021
No Relevant Pharmacokinetic Drug-Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects.

Yu Kyong Kim, Jun Gi Hwang, Min Kyu Park

Pageof 2

Frequent Collaborators

3 joint publications

SeungHwan Lee

2 joint publications

Mu Seong Ban

2 joint publications

Kyung-Sang Yu

2 joint publications

Jun Gi Hwang